Pharma Industry Consulting

Among the most constrained in terms of safety and regulations, the Health sector is marked by an unprecedented health crisis which has further increased the pressure.

Actors Impacted By:

• Changes in health policy: gradual reduction in reimbursement rates, additional stocks,
• The emergence of new, more agile and digital players (Startup – biotechnology, etc.),
• Increasingly strong regulations with specificities per country and the need to invest heavily to comply,
• A transformation of professions with the arrival of digital and AI / Machine learning which are transforming the daily lives of teams (Operations, Supply Chain, AI, clinical trials, traceability, etc.),
• Strong organizational and performance issues related to a very active sector: change of strategy, build-up, carve-out, business combination, active investment fund, etc.

A Sector Where Each Player Has Their Own Constraints:

• Medical devices: a constant search for technological leaps and innovation,
• Pharmaceutical industry: strong pressure linked to generics, an explosion in costs, particularly in R&D, control of CDMOs in terms of sometimes complicated QCD, political pressure on the subject of strategic reindustrialization,
• Hospitals/clinics: a sector heavily used by economic pressure but also the demands of the patient,
• Home care: strong development, particularly due to the obligation to go on an outpatient basis for a large number of treatments, requiring an increase in-home care.

​

Agility is at the heart of the challenges for the entire healthcare industry.